Condition: Central-line Associated Blood Stream Infections (CLABSI) · Sponsor: Rabin Medical Center
Our aim is to test the effect of tissue adhesive application at the Central-line exit-site on CLABSI rates in high-risk pediatric congenital heart disease patients.
This description comes directly from the study's public registry record.
Eran Shostak, MD · 972-3-9253114 · eransho@clalit.org.il
Always discuss trial participation with your own doctor first.
| Schneider's children medical center | Petah Tikva, Israel | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05721677